Skip to content
April 21, 2025

RNA-LNP Therapeutics for Resistant Melanoma

Ravi Amaravadi’s Abstract Melanoma, a deadly form of skin cancer, often becomes resistant to current treatments, particularly immunotherapy. Although melanoma tumors ...

2 Minute Read
February 26, 2025

Genetic Drivers of Cutaneous Melanoma: Racial Disp...

Julyssa Renteria’s Abstract Melanoma, a serious type of skin cancer, affects people differently based on their racial background. Non-Caucasian groups, such as Black,...

1 Minute Read
February 26, 2025

Comparing mutational landscape of melanoma across ...

Marin Melloy’s Abstract Melanoma causes the most deaths among skin cancers, and cases have been rising in recent years. While we know some of the main genetic factors...

2 Minute Read
February 26, 2025

Regulating Golgi Structure to Improve Melanoma-Rea...

Kathleen N Klinzing’s Abstract The immune system can recognize and kill cancer cells. One cell type that excels at this is the cytotoxic T cell, or CD8+ T cell. CD8+ ...

2 Minute Read
February 26, 2025

Investigating T cell tolerance in nevi and its rol...

Hannah Wu’s Abstract This research explores the intricate relationship between proteins in the tumor environment, known as the extracellular matrix (ECM), and the beh...

2 Minute Read
February 26, 2025

Leveraging T cell genetic variants to enhance mela...

Zachary Walsh’s Abstract T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly pro...

2 Minute Read
February 26, 2025

Understanding Perceptions and Barriers to Melanoma...

Yingjoy Li’s Abstract Melanoma is the deadliest type of skin cancer. Although it mostly affects people with lighter skin, those with darker skin, including Asian, Asi...

2 Minute Read
February 26, 2025

Using AI to Identify Challenging Ambiguous Spitzoi...

Jordan Bui’s Abstract The use of artificial intelligence (AI) in dermatology is becoming increasingly prevalent and advancing rapidly. Current research has demonstrat...

2 Minute Read
February 26, 2025

Boosting Melanoma Immunity with Sequential IL-2 an...

Jack Kollings’ Abstract Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapyâ...

2 Minute Read
February 26, 2025

Defining drivers and metastatic risk of AP-1 heter...

Kimberly Nguyen’s Abstract Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, bring...

2 Minute Read
February 26, 2025

Mitigating Local Recurrence Risk for Melanoma Pati...

Anjali Devireddy’s Abstract Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The prese...

1 Minute Read
December 23, 2024

Tumor Draining Lymph Nodes to Predict Response to ...

August Culbert’s Abstract Metastatic melanoma remains a significant cause of death in the United States, with average survival rates below 35% just 5 years after init...

2 Minute Read

Nov 22, 2025 PT

Saint John’s Cancer Institute Patient & Caregiver Symposium

Dec 02, 2025 ET

Ask The Expert: LAG-3 Inhibitors: Exploring a New Path in Melanoma Treatment

Dec 06, 2025 ET

Tampa Bay Miles for Melanoma 5K

Dec 13, 2025 ET

Fort Myers Miles for Melanoma 5K

Feb 08, 2026 ET

Miami Miles for Melanoma 5K

Feb 22, 2026 ET

Orange County Miles for Melanoma 5K

Mar 01, 2026 ET - Mar 03, 2026

2026 Advocacy Days

Explore Events